Program
PF-07258669
Its studies are led by Pfizer.
Furthest: phase 1, since Nov 9, 20204 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pfizer | 40 open or running | phase 1since Nov 9, 2020 | Nov 9, 2020 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 9, 2020First study: phase 1 study in Healthy ParticipantsFirst studyNCT04628793 · 29 enrolled · United States
- Oct 13, 2021Phase 1 study in Healthy ParticipantsNCT05113940 · 120 enrolled · Belgium
- Nov 21, 2024Phase 1 study in HealthyNCT06706869 · 26 enrolled · United States
- Jul 18, 2025Phase 1 study in Healthy VolunteersNCT07086664 · 7 enrolled · United States, Canada, Japan
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07086664Healthy Volunteers · United States, Canada, Japan | 1 | Terminated | Jan 21, 2026 | 7 |
| NCT06706869Healthy · United States | 1 | Completed | Feb 20, 2025 | 26 |
| NCT05113940Healthy Participants · Belgium | 1 | Completed | Jul 27, 2023 | 120 |
| NCT04628793Healthy Participants · United States | 1 | Completed | Aug 25, 2021 | 29 |
How it is read
Names in the registry
- “PF-07258669”, 4 entries
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.